JP2012505836A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012505836A5 JP2012505836A5 JP2011531305A JP2011531305A JP2012505836A5 JP 2012505836 A5 JP2012505836 A5 JP 2012505836A5 JP 2011531305 A JP2011531305 A JP 2011531305A JP 2011531305 A JP2011531305 A JP 2011531305A JP 2012505836 A5 JP2012505836 A5 JP 2012505836A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- benzofuran
- oxadiazol
- diol
- propane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008905369A AU2008905369A0 (en) | 2008-10-17 | S1P Receptors Modulators and Their use Thereof | |
| AU2008905369 | 2008-10-17 | ||
| AU2009903644 | 2009-08-05 | ||
| AU2009903644A AU2009903644A0 (en) | 2009-08-05 | S1P Receptors Modulators and their use Thereof | |
| PCT/AU2009/001371 WO2010043000A1 (en) | 2008-10-17 | 2009-10-19 | S1p receptors modulators and their use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014192502A Division JP5963823B2 (ja) | 2008-10-17 | 2014-09-22 | Ｓ１ｐ受容体モジュレーターおよびそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012505836A JP2012505836A (ja) | 2012-03-08 |
| JP2012505836A5 true JP2012505836A5 (cg-RX-API-DMAC10.html) | 2013-02-07 |
Family
ID=42106136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011531305A Pending JP2012505836A (ja) | 2008-10-17 | 2009-10-19 | Ｓ１ｐ受容体モジュレーターおよびそれらの使用 |
| JP2014192502A Active JP5963823B2 (ja) | 2008-10-17 | 2014-09-22 | Ｓ１ｐ受容体モジュレーターおよびそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014192502A Active JP5963823B2 (ja) | 2008-10-17 | 2014-09-22 | Ｓ１ｐ受容体モジュレーターおよびそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8592399B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2344484B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2012505836A (cg-RX-API-DMAC10.html) |
| CN (1) | CN102186845B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2009304598B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2740484C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2590904T3 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ592748A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2010043000A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010042998A1 (en) | 2008-10-17 | 2010-04-22 | Akaal Pharma Pty Ltd | S1p receptors modulators |
| JP2012505836A (ja) | 2008-10-17 | 2012-03-08 | アカール ファーマ ピーティーワイ リミテッド | Ｓ１ｐ受容体モジュレーターおよびそれらの使用 |
| WO2010093704A1 (en) * | 2009-02-10 | 2010-08-19 | Abbott Laboratories | Agonists and antagonists of the s1p5 receptor, and methods of uses thereof |
| JP6107660B2 (ja) * | 2010-11-30 | 2017-04-05 | 艾達索高新材料蕪湖有限公司 | 再加工可能なエポキシ樹脂のための新規薬剤 |
| EP2697195A1 (en) | 2011-04-14 | 2014-02-19 | Allergan, Inc. | Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators |
| CN102993027B (zh) * | 2011-09-08 | 2014-08-13 | 中化蓝天集团有限公司 | 4-氟-n-异丙基苯胺的定向单烷基化制备方法 |
| CN104144927B (zh) | 2011-12-23 | 2016-08-24 | 明治制果药业株式会社 | S1p受体调节剂 |
| US9376409B2 (en) | 2012-05-09 | 2016-06-28 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
| KR102127025B1 (ko) | 2012-07-27 | 2020-06-25 | 비오겐 엠에이 아이엔씨. | S1p 조절제 및/또는 atx 조절제인 화합물들 |
| US8859598B2 (en) | 2012-10-04 | 2014-10-14 | Allergan, Inc. | 1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators |
| WO2014063199A1 (en) * | 2012-10-26 | 2014-05-01 | Akaal Pharma Pty Ltd | Organic compounds |
| ES2755772T3 (es) | 2012-11-07 | 2020-04-23 | Nerviano Medical Sciences Srl | Pirimidinil y piridinilpirrolopiridinonas sustituidas, proceso para su preparación y su uso como inhibidores de cinasas |
| US8735433B1 (en) * | 2012-11-14 | 2014-05-27 | Allergan, Inc. | Aryl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| CN103304503B (zh) * | 2013-06-02 | 2015-03-04 | 张远强 | 抗糖尿病化合物、其制备方法和用途 |
| CN103304499B (zh) * | 2013-06-02 | 2015-03-04 | 张远强 | 抗糖尿病化合物、其制备方法和用途 |
| WO2015023839A1 (en) * | 2013-08-15 | 2015-02-19 | Allergan, Inc. | Aryl azetidine derivatives as sphingosine-1 phosphate receptors modulators |
| JPWO2015129859A1 (ja) * | 2014-02-28 | 2017-03-30 | キッセイ薬品工業株式会社 | 新規なアニリン誘導体、それを含有する医薬組成物およびそれらの用途 |
| EP3268358A1 (en) | 2015-03-13 | 2018-01-17 | Forma Therapeutics, Inc. | Alpha-cinnamide compounds and compositions as hdac8 inhibitors |
| MA42625A (fr) * | 2015-08-11 | 2018-06-20 | Akaal Pharma Pty Ltd | Compositions comprenant des modulateurs de récepteurs de s1p |
| ES2880766T3 (es) | 2016-02-09 | 2021-11-25 | Pharmakea Inc | Inhibidores de quinolinona lisil oxidasa similar al tipo 2 y usos de los mismos |
| EP3558950B1 (en) | 2016-12-20 | 2023-05-10 | Oligomerix, Inc. | Novel quinazolinones that inhibit the formation of tau oligomers and their method of use |
| EP3562483B1 (en) | 2016-12-20 | 2025-09-03 | Oligomerix, Inc. | Novel benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use |
| AU2018282747B2 (en) | 2017-06-14 | 2024-01-18 | Trevena, Inc. | Compounds for modulating S1P1 activity and methods of using the same |
| KR102017324B1 (ko) * | 2018-04-30 | 2019-09-02 | 경북대학교 산학협력단 | 신규한 asm 활성 직접 억제 화합물 2-아미노-2-(1,2,3-트리아졸-4-일)프로판-1,3-디올 유도체 및 이의 용도 |
| US11801242B2 (en) | 2018-10-09 | 2023-10-31 | Duke University | Compositions and methods for adjuvant cancer therapeutics |
| CN111630029B (zh) * | 2018-12-06 | 2021-04-30 | 上海济煜医药科技有限公司 | 作为免疫调节剂的化合物及其制备方法和应用 |
| CN109824685B (zh) * | 2019-04-03 | 2021-03-23 | 辽宁中医药大学 | 马齿苋中化合物oleracone G及其提取分离方法与应用 |
| AU2020341464A1 (en) * | 2019-09-05 | 2022-04-21 | Trevena, Inc. | Methods of treating epilepsy using the same |
| US11884655B2 (en) | 2019-11-19 | 2024-01-30 | Trevena, Inc. | Compounds and methods of preparing compounds S1P1 modulators |
| CA3169569A1 (en) * | 2020-02-28 | 2021-09-02 | Damian Grobelny | S1p receptor modulators |
| BR112023018676A2 (pt) | 2021-03-18 | 2023-10-10 | Seagen Inc | Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco |
| TW202430514A (zh) | 2022-09-30 | 2024-08-01 | 瑞士商先正達農作物保護股份公司 | 殺微生物之吡唑衍生物 |
| TW202430031A (zh) | 2022-09-30 | 2024-08-01 | 瑞士商先正達農作物保護股份公司 | 殺微生物之吡唑衍生物 |
| CN120282962A (zh) | 2022-11-30 | 2025-07-08 | 先正达农作物保护股份公司 | 杀微生物的四氢异喹啉衍生物 |
| WO2025114167A1 (en) | 2023-11-28 | 2025-06-05 | Syngenta Crop Protection Ag | Microbiocidal pyrazole derivatives |
| WO2025191053A1 (en) | 2024-03-14 | 2025-09-18 | Syngenta Crop Protection Ag | Microbiocidal pyrazole derivatives |
| WO2025210095A1 (en) | 2024-04-03 | 2025-10-09 | Syngenta Crop Protection Ag | Microbiocidal tetrahydroisoquinoline compounds |
| WO2025210096A1 (en) | 2024-04-03 | 2025-10-09 | Syngenta Crop Protection Ag | Fungicidal compositions |
| CN118878551A (zh) * | 2024-07-08 | 2024-11-01 | 安徽大学 | 一种4-溴噻吩并[2,3-c]吡啶-2-羧酸乙酯的制备方法 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2550646A (en) | 1947-08-21 | 1951-04-24 | Commercial Solvents Corp | Polyamino alcohols and method for preparing them |
| EP0513387B1 (en) | 1990-11-30 | 2000-03-01 | Otsuka Pharmaceutical Co., Ltd. | Thiazole derivatives as active oxygen inhibitors |
| AU674613B2 (en) * | 1993-09-28 | 1997-01-02 | Otsuka Pharmaceutical Co., Ltd. | Quinoxaline derivative as antidiabetic agent |
| FR2719044B1 (fr) * | 1994-04-26 | 1996-05-31 | Cird Galderma | Nouveaux composés bi-aromatiques acétylénés à groupement adamantyle, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| JP3964478B2 (ja) | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬 |
| US6221865B1 (en) | 1995-11-06 | 2001-04-24 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
| FR2741876B1 (fr) * | 1995-12-01 | 1998-01-09 | Cird Galderma | Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
| JPH10158192A (ja) * | 1996-10-03 | 1998-06-16 | Eisai Co Ltd | 移植片対宿主疾患（ｇｖｈｄ）の治療および臓器移植時の移植片拒絶反応抑制のための医薬組成物 |
| US6228868B1 (en) | 1998-07-27 | 2001-05-08 | Abbott Laboratories | Oxazoline antiproliferative agents |
| BR9916318A (pt) | 1998-12-18 | 2001-08-14 | Basilea Pharmaceutica Ag | Compostos bicìclicos |
| CA2393027A1 (en) * | 1999-12-17 | 2001-06-21 | Abbott Laboratories | Inhibitors of interleukin 5 gene expression |
| JP4612990B2 (ja) * | 2001-03-16 | 2011-01-12 | アボット・ラボラトリーズ | ヒスタミン−３受容体リガンドとしての新規アミンおよびそれらの治療的適用 |
| US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| TW200304375A (en) | 2001-12-06 | 2003-10-01 | Maxia Pharmaceuticals Inc | 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer |
| WO2004047724A2 (en) * | 2002-05-16 | 2004-06-10 | Genelabs Technologies, Inc | Aryl and heteroaryl compounds as antibacterial and antifungal agents |
| EP1572693A1 (en) * | 2002-12-20 | 2005-09-14 | Pharmacia Corporation | Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
| EP2172472B1 (en) * | 2003-02-18 | 2012-12-26 | Kyorin Pharmaceutical Co., Ltd. | Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor |
| MXPA05012459A (es) * | 2003-05-19 | 2006-02-22 | Irm Llc | Compuestos y composiciones inmunosupresoras. |
| ES2527117T3 (es) | 2003-08-29 | 2015-01-20 | Ono Pharmaceutical Co., Ltd. | Compuesto capaz de unirse a receptor SIP y uso farmacéutico del mismo |
| CN1859904A (zh) | 2003-10-03 | 2006-11-08 | 默克公司 | 用于治疗阿尔茨海默氏病的苄醚和苄氨基β－分泌酶抑制剂 |
| TW200538433A (en) | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
| CN101006053A (zh) | 2004-06-18 | 2007-07-25 | 比奥里波克斯公司 | 用于治疗炎症的吲哚 |
| US20060223866A1 (en) * | 2004-08-13 | 2006-10-05 | Praecis Pharmaceuticals, Inc. | Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity |
| WO2006022442A1 (ja) * | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
| AU2005307818A1 (en) | 2004-11-18 | 2006-05-26 | The Institutes For Pharmaceutical Discovery, Llc | Heterocyclylbiphenyl derivates as protein Tyrosine phosphatase inhibitors |
| US7829585B2 (en) | 2005-03-30 | 2010-11-09 | Eisai R&D Management Co., Ltd. | Antifungal agent containing pyridine derivative |
| JPWO2006115188A1 (ja) | 2005-04-22 | 2008-12-18 | 第一三共株式会社 | ヘテロ環化合物 |
| FR2887882B1 (fr) | 2005-07-01 | 2007-09-07 | Sanofi Aventis Sa | Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique |
| AU2006283175A1 (en) * | 2005-08-23 | 2007-03-01 | Irm Llc | Immunosuppressant compounds and compositions |
| JP2007169194A (ja) | 2005-12-21 | 2007-07-05 | Kyorin Pharmaceut Co Ltd | ジオキサフォスフォリナン誘導体とその付加塩及びスフィンゴシン−１−リン酸（ｓ１ｐ１，ｓ１ｐ４）受容体作動薬 |
| WO2007076055A2 (en) | 2005-12-22 | 2007-07-05 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| DK1962830T3 (da) * | 2005-12-23 | 2013-06-24 | Glaxosmithkline Llc | Azaindolhæmmere af aurorakinaser. |
| WO2007092638A1 (en) | 2006-02-09 | 2007-08-16 | University Of Virginia Patent Foundation | Bicyclic sphingosine 1-phosphate analogs |
| JP5099005B2 (ja) * | 2006-04-03 | 2012-12-12 | アステラス製薬株式会社 | ヘテロ化合物 |
| CL2007001166A1 (es) * | 2006-04-26 | 2008-01-25 | Piramed Ltd | Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica |
| TW200823182A (en) * | 2006-08-01 | 2008-06-01 | Praecis Pharm Inc | Chemical compounds |
| MX2009001788A (es) | 2006-08-17 | 2009-09-23 | Univ Chicago | Tratamiento de enfermedades inflamatorias. |
| JP2009269819A (ja) | 2006-08-25 | 2009-11-19 | Asahi Kasei Pharma Kk | アミン化合物 |
| AU2007323540A1 (en) * | 2006-11-21 | 2008-05-29 | University Of Virginia Patent Foundation | Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| BRPI0717907A2 (pt) | 2006-12-07 | 2013-11-05 | Genentech Inc | "composto, composição farmacêutica, métodos para tratar um câncer, para inbir ou modular a atividade da lipídeo quinase, processo para a produçãoo de uma composição farmacêutica, uso de um composto e kit" |
| AR064155A1 (es) * | 2006-12-07 | 2009-03-18 | Piramed Ltd | Compuestos de inhibidores de fosfoinositido-3 quinasa y metodos de uso |
| US20080167286A1 (en) * | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
| US8486979B2 (en) * | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
| TW200838497A (en) | 2006-12-21 | 2008-10-01 | Abbott Lab | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| JP5198293B2 (ja) | 2007-02-13 | 2013-05-15 | 杏林製薬株式会社 | アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤 |
| KR101222412B1 (ko) | 2007-02-15 | 2013-01-15 | 에프. 호프만-라 로슈 아게 | Ｔａａｒ1 리간드로서의 2-아미노옥사졸린 |
| EP2014653A1 (en) * | 2007-06-15 | 2009-01-14 | Bioprojet | Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| US20090118349A1 (en) | 2007-08-16 | 2009-05-07 | Onco-Pharmakon Incorporated | Bis-alkylating agents and their use in cancer therapy |
| US20100010053A1 (en) | 2008-06-20 | 2010-01-14 | Jose Luis Castro Pineiro | Compounds |
| JP2012505836A (ja) * | 2008-10-17 | 2012-03-08 | アカール ファーマ ピーティーワイ リミテッド | Ｓ１ｐ受容体モジュレーターおよびそれらの使用 |
| WO2010042998A1 (en) | 2008-10-17 | 2010-04-22 | Akaal Pharma Pty Ltd | S1p receptors modulators |
| US20100160369A1 (en) | 2008-12-04 | 2010-06-24 | Exelixis, Inc. | S1P1 Agonists and Methods of Making And Using |
| CN102245602B (zh) | 2008-12-18 | 2014-09-10 | 默克雪兰诺有限公司 | 用于治疗多发性硬化症的与恶二唑稠合的杂环衍生物 |
| WO2014063199A1 (en) * | 2012-10-26 | 2014-05-01 | Akaal Pharma Pty Ltd | Organic compounds |
-
2009
- 2009-10-19 JP JP2011531305A patent/JP2012505836A/ja active Pending
- 2009-10-19 EP EP09820119.7A patent/EP2344484B1/en active Active
- 2009-10-19 US US13/124,549 patent/US8592399B2/en active Active
- 2009-10-19 ES ES09820119.7T patent/ES2590904T3/es active Active
- 2009-10-19 AU AU2009304598A patent/AU2009304598B2/en active Active
- 2009-10-19 NZ NZ592748A patent/NZ592748A/xx unknown
- 2009-10-19 CN CN200980141188.9A patent/CN102186845B/zh active Active
- 2009-10-19 CA CA2740484A patent/CA2740484C/en active Active
- 2009-10-19 WO PCT/AU2009/001371 patent/WO2010043000A1/en not_active Ceased
-
2013
- 2013-10-29 US US14/066,276 patent/US9193716B2/en active Active
-
2014
- 2014-09-22 JP JP2014192502A patent/JP5963823B2/ja active Active
-
2015
- 2015-10-22 US US14/920,780 patent/US9707205B2/en active Active